Neurocrine Analysis Finds 6-Point EQ-VAS Gain Clinically Relevant
An analysis by Neurocrine found that a 6-point improvement on the EQ-VAS is clinically relevant in tardive dyskinesia.
An analysis by Neurocrine found that a 6-point improvement on the EQ-VAS is clinically relevant in tardive dyskinesia.